FDA Approves Novel Device to Remotely Monitor HF Patients
The U.S. Food and Drug Administration (FDA) has approved the CardioMEMS HF System, an implantable wireless device with remote monitoring capabilities used to measure pulmonary artery (PA) pressure in heart failure patients with New York Heart Association Class III heart failure who have been hospitalized for the condition in the previous year. "This is the first permanently implantable wireless system intended to provide PA pressure measurements, including systolic, diastolic and mean PA pressures," notes the FDA. "The PA pressure data are reviewed by physicians who can make decisions regarding the status of the patient and, if necessary, initiate changes in medical therapy, with the goal of reducing hospitalization due to heart failure."
< Back to Listings